BioCure
Private Company
Total funding raised: $5.0M
Overview
BioCure is a private, likely revenue-generating biotechnology company based in Peachtree Corners, Georgia, focusing on advanced polymer-based medical devices. The company's core competency lies in custom-engineered PVA hydrogels and amphiphilic block copolymers, which are applied across three primary areas: active drug delivery, implantable devices, and dermal barriers. With a foundation built on decades of PVA experience, BioCure operates through a hybrid business model of proprietary product development (like Bead Block) and collaborative R&D/manufacturing services for other companies. Its primary markets are in oncology and interventional medicine, with potential expansion into broader immunology and dermatology sectors.
Technology Platform
Expertise in custom Polyvinyl Alcohol (PVA) hydrogels and amphiphilic block copolymers for creating biocompatible, in-situ forming implants, drug delivery depots, and dermal membranes.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
BioCure competes in the advanced biomaterials space against large medical device companies (e.g., BD, Boston Scientific) with hydrogel offerings, specialty drug delivery companies, and other innovative startups. Its differentiation lies in its deep, specific expertise in PVA chemistry and its proven ability to translate that into a commercial, best-in-class embolic product.